{"database": "openregs", "table": "dockets", "rows": [["FDA-2006-D-0356", "FDA", "Guidance for Industry and Food and Drug Administration Staff; Draft Class II Special Controls Guidance Document: Absorbable Hemostatic Device", "Nonrulemaking", "2021-09-01T01:01:36Z", "0b0000648045f67c"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2006-D-0356"], "units": {}, "query_ms": 38.65166998002678, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}